跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 510 条关于
“Keynote”
全部
510
临床试验
200
药物
4
机构
1
资讯
305
2年前
Merck Discontinues Phase 3 Trials of Pembrolizumab in NSCLC and CSCC
2年前
KEYNOTE-789: Pembrolizumab Plus Chemotherapy Fails to Improve Survival in EGFR-Mutated NSCLC
去年
Pembrolizumab Plus Chemotherapy Improves Overall Survival in HER2-Positive Gastric Cancer
2年前
Pembrolizumab Demonstrates Sustained Survival Benefits in Advanced Melanoma After 10-Year Follow-Up
2年前
Pembrolizumab Improves Overall Survival in Clear Cell Renal Cell Carcinoma
2年前
Pembrolizumab Shows Sustained Survival Benefit in Advanced Melanoma After 10-Year Follow-up
3个月前
The Evolving Role of Biotechnology Keynote Speakers in Shaping Pharmaceutical R&D Strategy
2个月前
NBJ Summit 2026 Announces Keynote Lineup: AI-Driven Healthcare, Biohacking, and Leadership Take Center Stage
2年前
Pembrolizumab Plus Chemotherapy Improves Overall Survival in Early-Stage TNBC
去年
CAR T-Cell Therapy Shows Improved Survival in Transformed Follicular Lymphoma
第 1 页,共 31 页
上一页
下一页